Spotlight on Antibodies

Spotlight on Antibodies is a podcast from ⁠Biointron⁠, where we bring you the latest antibody industry trends. This month in May, we'll highlight the future of VHH technology, chemical conjugation in antibody therapeutics, and emerging trends in antibody characterization.References:https://www.tandfonline.com/doi/full/10.1080/19420862.2025.2516676https://academic.oup.com/peds/article/doi/10.1093/protein/gzaf010/8262225https://academic.oup.com/bioinformaticsadvances/article/4/1/vbae033/7623636https://www.nature.com/articles/s42003-026-09594-yhttps://pubs.acs.org/doi/10.1021/polymscitech.5c00080https://pmc.ncbi.nlm.nih.gov/articles/PMC12203927/https://link.springer.com/article/10.1186/s11671-025-04200-2https://pubs.acs.org/doi/full/10.1021/acs.bioconjchem.3c00040https://www.nature.com/articles/s41598-023-43431-0https://www.cell.com/cell-reports-methods/fulltext/S2667-2375(26)00116-5https://www.mdpi.com/1424-8247/16/2/291

Spotlight on Antibodies is a podcast from ⁠Biointron⁠, where we bring you the latest antibody industry trends. This month, in April, we'll highlight ATP-dependent switch antibodies, the throughput-quality gap in antibody discovery, and multiple myeloma antibody treatments.References:   https://link.springer.com/article/10.1007/s40259-025-00752-yhttps://www.sciencedirect.com/science/article/pii/S221112472031531Xhttps://link.springer.com/article/10.1208/s12248-026-01238-7https://www.annalsofoncology.org/article/S0923-7534(25)03071-6/fulltexthttps://aacrjournals.org/cancerdiscovery/article/11/1/158/2793/Antibody-to-CD137-Activated-by-Extracellularhttps://link.springer.com/article/10.1208/s12248-026-01238-7https://jitc.bmj.com/content/14/1/e013397https://link.springer.com/article/10.1007/s40200-024-01386-7https://link.springer.com/article/10.1186/s13036-025-00513-zhttps://academic.oup.com/abt/article/6/1/13/6823522https://www.clinical-lymphoma-myeloma-leukemia.com/article/S2152-2650(24)02423-6/fulltext